Yemen vs Zambia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Yemen
0.5%
in 2024
Zambia
0.4%
in 2024
Yemen rank
71st
Zambia rank
74th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Yemen
- Zambia
How they compare
Yemen currently reports 0.5% against 0.4% in Zambia, a difference of 0.1%.
That makes Yemen's figure about 1.2 times Zambia's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Zambia ahead.
Yemen ranks 71st and Zambia ranks 74th of 246 countries.
Yemen has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Yemen | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.6% | 0.6% | 0.1% | Yemen |
| 2020s | 0.5% | 0.4% | 0.1% | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Yemen or Zambia?
- Yemen, at 0.5% against 0.4% in Zambia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Yemen and Zambia?
- 0.1%, with Yemen ahead.
- How many years of comparable data are there for Yemen and Zambia?
- 10 years are reported by both, from 2015 to 2024.
- How do Yemen and Zambia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Yemen ranks 71st and Zambia ranks 74th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.